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INTRODUCTION 
 
Insight is defined in the Webster’s dictionary as ‘the understanding or 
awareness of one's mental or emotional condition; especially, a recognition that 
one is mentally ill’. 
Insight is an elusive concept with a long history of divergent and 
inconsistent definitions and measurements (Amador & David, 1998). 
Until the early nineteenth century, the official view of insanity was 
based on the presence of delusions which were, in turn, embedded in an 
implicit lack of insight. Lack of insight was thus not a variable but a parameter 
of insight (Amador and David, 2004).  
The developments of concepts such as partial, emotional and volitional 
insanity during the second half of the nineteenth century led to the examination 
of the value of evaluating the attitude of patients vis a vis their insanity 
(Markova and Berrios, 2004). 
The term “anosognosia” was first used by the French neurologist 
Babinski to describe denial of motor deficits in neurological disease.  
Traditional views of insight considered it to be a single homogenous 
entity which was non reducible and hence rated as a single item however 
interest in this area has been revived by many current authors who have 
proposed new models to understand and explain insight.  
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Interest in studying insight is also fueled by an increasing desire to 
elucidate the correlates of insight and its causal origins. This desire is 
strengthened by studies which point to a key role of insight in mediating 
treatment compliance and outcome.  
Research into insight is also influenced by current theories of 
schizophrenia which consider enduring neurocognitive deficits due to brain 
dysfunction as being a core component of the disorder.  
However despite being the focus of intensive research in the past 
decade, though much progress has been made in the measurement of insight, 
the foundations of impaired insight are still remain elusive. Studies focusing on 
the relation between neuropsychological deficits and insight are often 
contradictory and hampered by methodological, operational and consistency 
problems.  
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REVIEW OF LITERATURE 
In 1934, Aubrey Lewis provided a temporary definition of Insight: “a 
correct attitude to morbid change in oneself”, but warned that the words 
‘correct’, ‘attitude’, ‘morbid’ and ‘change’ each called for discussion (Lewis, 
1934). 
Current authors agree that insight is multidimensional and not a unitary 
phenomenon. The component dimensions of insight are continuous rather than 
dichotomous phenomena (Amador et al, 1993). 
Insight into one’s own psychosis is not an ‘all or- none’ phenomenon 
but can be conceived of as a multidimensional construct and is composed of 
three distinct, overlapping dimensions, namely, recognition that one has a 
mental illness, compliance with treatment, and ability to re-label unusual 
mental events (delusions and hallucinations) as pathological (David, 1990). 
Patients with schizophrenia have multiple deficits in self-awareness and 
that this unawareness can be modality specific, i.e., one can have poor 
awareness of thought disorder but recognize that he or she suffers from false 
perceptions (Amador et al, 1994).  
Insight comprises process of awareness and attribution. Awareness is the 
recognition of signs (or) symptoms of illness, while attribution refers to 
explanations about the cause source of the signs (or) symptom. Insight 
assessment also includes retrospective views about illness (Amador et al, 
1993). 
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This understanding of a multi dimensional model of insight has given 
rise to scales like the Scale to assess Unawareness of Mental Disorders 
(SUMD) which are more comprehensive measures of insight (Amador and 
Strauss, 1990). 
There is also an increasing interest in understanding lack of insight in 
schizophrenia as an ‘anosognosia’ (Laroi et al, 2004) 
Models of Insight 
Despite progress in defining and measuring insight, the nature of 
unawareness of illness in patients with schizophrenia remains poorly 
understood (Freudenreich et al, 2004). The more recent, empirical literature 
points in several directions.  
First, insight might simply be part and parcel of schizophrenia, a 
symptom that cannot be further reduced (Cuesta and Peralta 1994a). 
Secondly, lack of insight could stem from a neurological deficit akin to 
anosognosia. (Amador et al 1991) 
Thirdly, affective experiences, such as euphoria (Ghaemi et al, 1995), 
depression or anxiety (Michalakeas et al, 1994; Smith et al 2000) may play a 
role in insight. 
Lastly, it has been suggested but not tested empirically that insight or 
lack of insight is a function of social labeling (Johnson & Orrell 1995). 
David & Kemp, consider two factors to be most important in the genesis 
of insight, first, that insight is an aspect of psychopathology, particularly 
delusions, and second that poor insight reflects a neuropsychological deficit 
(David & Kemp 1998).  
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Amador et al, (1991), give two main broad accounts of variations in 
insight that might be called motivational and defect theories.  The former 
assumes that individuals are aware of their illness in some sense but are 
motivated to deceive themselves (or others) about it in order to preserve their 
self-esteem, maintain an optimistic outlook, or some similar reason. Defect 
theories, on the other hand, assume that schizophrenic individuals are unable to 
recognize their illness as a result of some cognitive deficits. 
In the last few years there has been a definite shift in the literature away 
from the ‘psychology’ of poor insight and toward the identification of possible 
neuropsychological substrates (Takai et al., 1992; David et al., 1993; Collins et 
al, 1997). 
Anosognosia and Insight 
Poor insight in schizophrenia shares common features with anosognosia 
in neurological disorders such that both are largely resistant to direct 
confrontation and delusional explanations are often provided to explain 
circumstances such as hospitalizations (Cuesta and Peralta, 1994a). Lele and 
Joglekar (1998) have carried the analogy further, pointing out that both 
anosognosia and poor insight in schizophrenia can be either generalized 
(relating to all aspects of the disease) or domain-specific (patient is aware of 
certain symptoms or functional deficits, but not others). 
There is evidence that poor insight in Alzheimer’s disease is associated 
with lower regional cerebral blood flow in the right frontal lobe (Starkstein and 
Vazquez, 1995), as well as with severity of cognitive impairments (Migliorelli, 
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et al., 1995) and specific deficits in frontal/executive functions (Lopez et al., 
1994).  
Frontal and pre-frontal areas of the cortex have become increasingly 
implicated as primary areas of dysfunction in schizophrenia. Findings from 
neuropsychology, neuroradiology, and neurophysiology have largely 
converged in this regard (Seidman, 1993; Weinberger et al,, 1992).  
Importance of Insight 
Previous studies have estimated that 50–80% of patients with 
schizophrenia do not believe they have a disorder (Amador and Gorman, 
1998). Thus lack of insight is a common problem in schizophrenia 
Lack of insight or awareness of illness has been widely recognized as a 
clinically relevant outcome measure (Amador and Gorman, 1998). This is 
primarily due to an association between impaired insight and treatment non-
adherence (McEvoy et al, 1989; David et al, 1992; Perkins, 2002), poor 
psychosocial functioning (Dickerson et al, 1997; Amador et al., 1994), 
premorbid functional impairment (Debowska et al, 1998; Keshavan et al, 
2004), poorer global functioning (Pini et al, 2001), poor prognosis (Schwartz et 
al., 1997), involuntary hospitalizations (Kelly et al., 2004), greater violence 
(Buckley et al, 2004) and higher utilization of emergency services (Haro et al, 
2001). 
Insight in Schizophrenia 
Early clinical descriptions of schizophrenia identified lack of insight as a 
characteristic symptom of the illness (Lewis A, 1934). Schizophrenic patients 
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demonstrate comparably less insight than either schizoaffective or depressive 
patients (Amador et al., 1994; Michalakeas et al., 1994; Pini et al., 2001). 
Poor insight or denial of illness is a prevalent feature of schizophrenia 
(Carpenter et al., 1978; Wilson et al, 1986). Poor insight can be conceptualized 
as an expression of the disorder, much as hallucinations or delusions, and is 
noted to be an important discriminating factor in making subtype diagnoses of 
schizophrenia (Carpenter et al., 1976). 
Correlates of Insight 
In accordance with the multiple models of origin of poor insight in 
schizophrenia, insight is considered to have multiple correlates. They may be 
broadly grouped as clinical, psychopathological and neuropsychological 
correlates 
Insight and Social Variables 
Poor insight has been associated with female gender (Peralta and Cuesta, 
1998). This is contradicted by other studies (Keshavan et al, 2004; Mintz et al, 
2003) which do not find such an association.  
In a study by Sanz et al, in 1998, number of years of education showed a 
modest correlation with the score in Markova & Berrios Insight Scale. But 
none of the other insight scales showed a significant relationship between 
insight and years of education. In their study on 535 patients with first episode 
schizophrenia, Keshavan et al, (2004) found no evidence of a relation between 
education and both insight and cognition. 
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Thus overall findings suggest that the relationship between insight and 
socio demographic variables is small and not consistent. 
Insight and Clinical Variables 
Nakano et al, (2004) suggest a relation between poor insight and 
younger age. Similarly, Mintz et al, in a Meta-analytic review in 2003, had 
suggested a moderator effect of mean age of onset on insight. However other 
studies do not agree with this (Keshavan et al, 2004; Amador et al, 1994). 
Left handedness was linked to poor insight in a study by David in 1995. 
However there are no corroborative reports. 
Thompson et al, in 2001, demonstrated that compared to first-episode 
patients, individuals who had experienced multi-episodes of schizophrenia, 
showed greater awareness of having a mental disorder. However in an earlier 
study, Amador et al, had found that the number and duration of hospitalizations 
were not significantly correlated with insight (Amador et al, 1994). Prolonged 
illness duration has also been associated with poorer insight (Drake et al, 
2000). 
Insight and Psychopathology 
The studies examining the connection between insight and 
schizophrenic phenomenology have been hampered by varying definitions and 
measurements of insight and outcome, lack of structured assessments and 
standardized instruments as well as varying diagnostic practices (Kemp and 
Lambert, 1995). 
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Varying results have been reported about the relationship between lack 
of insight and global psychopathology. Some studies have found negative 
associations (David et al, 1992; Markova and Berrios, 1992b; Young et al, 
1993; Mintz et al, 2003) implying that insight becomes less with greater 
severity of psychosis but not others (McEvoy et al, 1989; Cuesta and Peralta, 
1994a),  
The majority of investigations that have assessed insight and positive 
symptoms have reported a moderate but statistically significant inverse 
relationship between the two variables (David et al, 1992; Takai et al, 1992; 
Markova and Berrios, 1992b; Amador et al, 1994; Michalakeas et al, 1994; 
Young et al, 1993; Kemp and Lambert, 1995). 
However there has also been suggestion that these two variables are 
actually independent of one another (Bartko et al, 1988; McEvoy et al, 1989 & 
1993; Heinrichs et al, 1985; Cuesta and Peralta, 1994b) and severity of positive 
psychotic symptoms does not influence insight.  
A meta-analysis on this area by Mintz et al, in 2003 of 40 published 
studies indicated a small positive relationship between lack of insight and 
positive symptoms. They also concluded that acute patient status moderated the 
relationship between insight and symptom clusters, meaning that during acute 
episodes, the relationship between insight and positive symptoms is stronger. 
In addition, specific symptoms like delusions (Kemp and Lambert, 
1995; Amador et al, 1994) and formal thought disorder (Lysaker et al, 1994b; 
Amador et al, 1994) have also been linked to insight deficits.   
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Impaired insight has also been associated with disorganized symptoms 
(Dickerson et al, 1996; Kim et al, 1997; Collins et al, 1997; Amador et al, 
1994). This association of disorganization and lack of insight is considered by 
some to be stronger than that with positive symptoms (Amador et al, 1994). 
Negative symptoms also are associated with poorer insight (Mintz et al, 
2003; Nakano et al, 2004; Kemp and Lambert, 1995). Some studies however 
suggest that the strength of this association is weaker than that for positive 
symptoms (Collins et al, 1997; Carroll et al, 1999). Amador et al, (1994) 
however suggest that there is no relationship between insight and negative 
symptoms except anhedonia.  
Similar mechanisms may underlie poor insight and negative symptoms 
in schizophrenia (Stolar et al, 1994; Hammer et al, 1995) since it has been 
argued that they both share the same neurological substrates in the brain 
Insight and Depression 
Insight has also been associated with depression in many studies (Peralta 
and Cuesta, 1994b; Kemp and Lambert, 1995; Moore et al, 1999; Morgan et al, 
2002; Mintz et al, 2003). Such findings have added weight to the motivational 
theories of insight, and lack of insight is viewed as a method of warding off 
depressive symptoms that may result from the awareness that one suffers from 
a chronic illness. Good insight is also linked in studies to both hopelessness and 
greater life time suicidal attempts (Kim CH et al, 2003) and to pessimism 
(Thompson, 1988). Amador et al, (1993), however, reported that higher levels 
of depression were associated with poor insight. 
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Neuropsychological Deficits and Schizophrenia 
It is now beyond question that the symptoms observed in schizophrenia 
include a range of cognitive neuropsychological deficits that may be more 
enduring than psychotic symptoms (Goldberg et al, 1993). 
Clearly an understanding of neuropsychological deficits is important 
from a clinical as well as a theoretical viewpoint. There is, however, still much 
debate about the nature of these deficits and how they relate to the psychotic 
symptoms of schizophrenia and also to the neurobiological substrate of this 
disorder. (Elliot et al, 1995)  
There is evidence for generalized intellectual decline associated with 
schizophrenia (Saykin et al, 1994) and it has also been argued that specific 
neuropsychological deficits may occur over and above this general impairment 
(Weimberger et al, 1986). 
Insight and Neuropsychology 
Neuropsychological theories of the etiology of poor insight in 
schizophrenia have suggested that unawareness of illness is, at least in part, the 
result of prominent and enduring neurocognitive impairments. Support for this 
hypothesis comes from several different sources. First, poor insight shares 
many clinical features in common with anosognosia (Amador, 1991), or 
unawareness of illness in neurological disorders. Secondly, factor analytical 
studies have consistently found that insight belongs to a psychopathological 
component composed primarily of symptoms of cognitive impairment (Bell et 
al, 1993; Kay et al, 1990). Finally, more recent studies have demonstrated that 
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poor insight predicts poorer performance on neuropsychological testing (Young 
et al, 1993; Lysaker et al, 1994a), and is possibly related to ventricular 
enlargement (Takai A et al, 1992). 
The neuropsychological view of insight is that awareness of illness and 
relabelling of symptoms may be higher order cognitive abilities. In particular, it 
is conceivable that these components of poor insight are primarily the result of 
(i) global cognitive compromise, (ii) impairments in executive function or (iii) 
a combination of various forms of cognitive impairment (Lysaker et al, 1998). 
Significant cognitive impairment across multiple domains is a core 
characteristic of schizophrenia. 
Frontal Lobe and Schizophrenia 
Many of the earliest theorists, Bleuler, Meynert, Kraepelin and 
Alzheimer, argued that the symptoms of schizophrenia may be related to the 
dysfunction of the frontal lobes, and this contention has now been resurrected 
(Robbins, 1990; Jaskiw & Weinberger, 1992). Weinberger (1988) noted that 
there is an intuitive plausibility that the brain area most associated with 
conscious thought should be compromised in a disease characterized by formal 
thought disorder. He also describes that there are neurological signs in 
schizophrenia that are reminiscent of those following frontal lobe damage 
(disturbed gait, posture and eye movements). 
Several authors (Flashman et al, 2004; Cuesta et al, 1995) have linked 
negative symptom pathology to decreasing performance on cognitive tests, 
particularly those that demonstrate frontal lobe function. Brown and White 
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(1991) also reported that patients with a higher rating of negative symptoms 
were found to have more impaired performance on frontal psychological tests. 
The Wisconsin Card Sorting Test (WCST) is the most widely used test 
of frontal and executive function. The scores on categories achieved and 
perseverative errors are most relevant in assessing frontal executive function 
(David et al, 2003) 
Frontal lobe and Executive Function 
Neurosurgical patients with damage to the frontal lobes and particularly 
the prefrontal cortex show significant impairments in executive functioning so 
that tests sensitive to frontal lobe dysfunction and tests of executive function 
tend to be considered as synonymous (Shallice, 1982; Owen et al, 1990) 
Impairments in tests of executive function have frequently been reported 
in neurosurgical patients with frontal lobe damage (e.g. Shallice, 1982; Owen 
et al, 1990) and the impairments of schizophrenics on executive tests described 
above are thus consistent with a theory of frontal lobe dysfunction. 
Frontal lobe and Insight 
The various studies that have demonstrated the poor performance of 
insight-impaired schizophrenia patients on tasks that require frontal lobe 
activation (Keshavan et al, 2004; Lele et al, 1998; Young et al, 1993) add 
evidence to the hypothesis that frontal lobe deficits are an important part of 
declining insight 
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Flashman et al, (2001), tested insight in schizophrenia patients as a 
function of neuroanatomic abnormalities in the frontal lobe. Their results 
showed an inverse correlation between unawareness and volumes of different 
frontal regions. 
Studies by Lysaker & Bell (1994a) found significant, yet small, 
correlations between insight and measures sensitive to frontal lobe dysfunction, 
However, Cuesta and Peralta (1994a) failed to replicate these results. 
Insight and Executive Function 
Some authors have found that executive function tasks such as the 
Wisconsin Card Sorting Test administered to individuals with poor insight 
show increased preservative responses and/or poor concept formation (Young 
et al, 1998; Lysaker & Bell, 1994a; Lysaker et al. 1998; Larøi et al. 2000). 
Individual components of insight have also been related to poor scores on 
executive function and fluency tests; a significant association was found 
between unawareness of symptoms and misattribution of negative symptoms 
and scores on such tests (Mohamed et al. 1999). Smith et al, (2000) reported 
that overall insight levels were not related to neuropsychological variables but 
more specifically, symptom misattribution was correlated with card sorting 
performance. However, several studies have failed to demonstrate that poor 
insight is related to neuropsychological deficits, including card sorting (Cuesta 
& Peralta, 1994a; Collins et al, 1997; Goldberg et al, 2001). Thus there is as yet 
no conclusive evidence to link impaired insight to cognitive deficits. 
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Lists of studies providing evidence for and against a neurocognitive 
basis for insight are tabulated below. 
Positive Negative 
Young et al, (1993),  
McEvoy et al, (1996),  
Young et al, (1998),  
Mohammed et al, (1999),  
Laroi et al, (2000),  
Chen et al, (2001),  
Lysaker et al, (2002),  
Drake and Lewis (2002),  
Keshavan et al, (2004),  
Shad et al, (2004),  
Shad et al., (2006),  
Aleman et al, (2006). 
Cuesta et al, (1995),  
Kemp and David (1996),  
Collins et al, (1997),  
Dickerson et al, (1997),  
Sanz et al, (1998),  
Arduini et al, (2003),  
Kim et al, (2003),  
Freudenreich et al, (2004) 
 
Thus despite extensive research about insight in the past decade, the 
results are far from conclusive and the origins of insight deficits remain elusive 
as ever. Some of the factors identified as being associated with insight include, 
severity of psychosis, depression, neurocognitive deficits especially those with 
their basis in the frontal lobe. Research in this area in India is not fully explored 
especially with reference to the cognitive basis of insight. 
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AIMS 
1. To determine the extent of insight deficits in schizophrenic inpatients 
2. To determine the sociodemographic and clinical correlates of insight in 
schizophrenia 
3. To examine the relation between depression and insight 
4. To examine the relation between severity of psychotic symptoms and 
insight 
5. To determine the relation between insight and executive function in 
inpatients with schizophrenia. 
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Null Hypothesis 
1. Insight is not correlated with socio demographic variables 
2. Insight is not correlated with clinical variables 
3. There is no association between Insight and depression 
4. Insight is not correlated with the severity of either positive or 
negative symptoms 
5. Insight is not associated with executive dysfunction in 
schizophrenia 
Materials 
1. A semi structured proforma for sociodemographic profile and 
relevant clinical data. 
2. Scale to assess Unawareness of Mental Disorder (SUMD) 
3. Scale for the Assessment of Positive Symptoms (SAPS) 
4. Scale for the Assessment of Negative Symptoms (SANS) 
5. Items G 12 (Lack of judgment and Insight) and G 2,3,4 & 6 - 
(Depression - Anxiety domain) in Positive and Negative 
Syndrome Scale (PANSS) 
6. Wisconsin Card Sorting Test (WCST) 
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METHODOLOGY 
The study was of a cross sectional nature done on a sample 
schizophrenic in patients admitted in the acute care wards of IMH Chennai for 
either an exacerbation of illness or an initial episode. Both male and female 
patients were chosen in equal number (30 each). Consecutive male and female 
patients with a diagnosis of schizophrenia admitted in the institute and 
fulfilling the criteria were chosen. The diagnosis of schizophrenia was made as 
per ICD 10 clinical criteria, independently by two persons, a senior psychiatrist 
and the investigator.  
Inclusion Criteria: 
• ICD 10 diagnosis of schizophrenia 
• Age between 18 and 40 years 
• Consent and cooperation for examination 
• Onset of illness after age 18 years  
• Informant available for detailed history 
Exclusion Criteria: 
• Age less than 18 years and greater than 40 years. 
• Patients who did not complete the evaluation 
• Onset of illness before 18 years 
• Comorbid organic illnesses 
• Comorbid substance dependence 
• Other comorbid Axis I diagnosis, excluding depression 
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Onset age less than 18 years was excluded to prevent inclusion of early 
onset schizophrenia that have high levels of cognitive dysfunction and hence 
could potentially confound the results. Similarly, patients aged greater than 40 
years were excluded so as to minimize the chances of age and illness chronicity 
influencing executive function scores. Comorbid substance dependence, Axis I 
disorders and organic illnesses were excluded for the same reason. Depression 
could not be excluded as it is considered as one of the variables influencing in 
insight. Informed and written consent was obtained. 
The interviews and assessments were done during the hospital stay of 
the patient prior to discharge. All assessments were done by the investigator. 
The assessment of psychopathology and insight was done before administration 
of the WCST so as to minimize interviewer bias. 
A single cross sectional assessment was done in which, all tests were 
administered preferably in a single sitting or within a few days of each other so 
as to maintain the cross sectional nature of the assessment. The study was 
naturalistic with regard to treatment adopted either in the past or in the current 
admission. 
INSIGHT ASSESSMENT 
Scale to assess Unawareness of Mental Disorder (SUMD) 
The Scale to assess Unawareness of Mental Disorder (SUMD) (Amador 
and Strauss, 1990) is a semi-structured interview and scale that was designed to 
evaluate the multidimensional nature of insight. Scores are rated on a five-point 
scale (1=complete awareness, 3= partial awareness and 5=no awareness). The 
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scale is modular and can be shortened or adapted in a number of ways. SUMD 
sub-scores consist of the three General items (unawareness of a mental 
disorder, unawareness of the achieved effects of medication and the 
unawareness of the social consequences of a mental disorder) and Unawareness 
and Misattribution sub scores of each major symptom (consisting of questions 
relating to awareness and attribution of the specific symptoms). The average of 
all items rated is used as the awareness and misattribution score. Some of the 
symptoms examined include delusions, hallucinations Alogia etc. In addition, 
the SUMD allows for independent assessment of current and retrospective 
insight. For the purpose of the present research, analysis was primarily focused 
on current items since the sample included patients with first episode 
schizophrenia. (Annexure V) 
Positive and Negative Syndrome Scale (PANSS) 
Insight was also assessed using the insight and judgment item (G 12) 
from the Positive and Negative Syndrome Scale (PANSS) (Kay SR et al, 1987) 
since most of the earlier studies in this area have used this single item measure. 
It incorporates the three dimensions of insight into one global rating, and has 
been found to possess a high degree of concordance with the total score from 
another widely accepted measure of insight, namely the Scale to Assess 
Unawareness of Mental Disorder (SUMD) (Annexure II) 
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CLINICAL ASSESSMENT 
Scale for the Assessment of Positive Symptoms (SAPS) 
The Scale for the Assessment of Positive Symptoms (SAPS) (Andreasen 
N, 1984) is a 34 item scale for use in schizophrenia. It is administered via a 
general clinical interview with some specific questions. All items are rated 
from 0 (absent) to 5 (Severe). Ratings from SAPS are divided into two 
symptom dimensions which include Psychoticism (delusions and 
hallucinations) and Disorganization (bizarre behavior, formal thought disorder 
and inappropriate affect). The SAPS is a well validated instrument and is 
widely used. (Annexure III). 
The Scale for the Assessment of Negative Symptoms (SANS) 
The Scale for the Assessment of Negative Symptoms (SANS) 
(Andreasen N, 1981) is a 25 item scale designed to assess negative symptoms 
in schizophrenia. The symptoms measured are alogia, affective flattening, 
avolition-apathy, anhedonia-asociality and inattention. The SANS is a popular 
and well validated and used both clinically and in research. (Annexure IV). 
Depression 
The depression-anxiety domain (items G2, G3, G4 & G6) in PANSS 
(Kay SR et al, 1987) was used to measure depression. The mean score on the 
four items was taken as the score on depression. The scores ranged on a likert 
scale from 1 = absent to 7 = extreme depression. Individual items and domains 
of the PANSS have been shown to be of good validity (Annexure II).  
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EXECUTIVE FUNCTION 
Wisconsin Card Sorting Test (WCST) 
The Wisconsin Card Sorting Test (WCST) (Heaton HK, 1981) is a 
neuropsychological test in which subjects sort cards that vary according to 
shape, color and the number of objects depicted. Subjects are told to match the 
cards to 'stimulus' cards but are not told the matching principle which changes 
after 10 consecutive correct responses. This study utilized five scores namely 
total errors, perseverative errors, perseverative responses, conceptual level 
responses and categories correct. The WCST is considered as the gold standard 
in the assessment of executive function with relative specificity for the frontal 
lobe. Studies which use the WCST in populations with cognitive dysfunction 
use the raw scores obtained rather than the standardized scores. This makes it 
applicable for the Indian population as well. The WCST is a non verbal test and 
can be used in a variety of settings. (Annexure VI). 
ANALYSIS 
The data collected was tabulated and analyzed with reference to the aims 
and objectives of the study. All statistical analysis was done using Statistical 
Package for Social Sciences (SPSS ver. 15. 0). A correlational analysis was 
used to assess the relation between the insight scores in different domains of 
the SUMD and continuous variables using Pearson’s correlation. The t - test 
was used to study the relation between insight and categorical variables. 
Multiple regression analysis was done to determine the independent effects of 
significant variables on insight. The level of significance was kept at p < 0.05. 
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RESULTS 
        
Assessment of insight and psychopathology was done on 60 patients. 
Since 4 of these patients (3 male, 1 female), could not be assessed for executive 
function (WCST) as they were discharged or absconded from the ward before 
they could be assessed, 4 more patients (3 male and 1 female) were assessed 
consecutively at the end so that the final sample taken for analysis was 60 
patients (30 male and 30 female) as per the study criteria. 
Table 1a  
 
Description of Social and Clinical Characteristics 
  
Variable Mean (n = 60) SD 
Age 29.3 5.85 
Education in years  8.8 3.51 
Age at onset 25.15 4.88 
Duration of Illness 4.17 2.94 
No. of Admissions 1.75 1.16 
 
SD – Standard Deviation 
 
The mean age of the study sample was 29. 3 years. The sample was 
selected to be in the age range of 18 to 40 hence the standard deviation is not 
high. Most patients had some form of schooling with the average years of 
schooling being 8.8 years. Few patients had graduated. The mean age at onset 
was 25.1 years. Mean duration of illness was 4.17 years. The mean number of 
admissions was 1.75. The number of patients in the sample who were admitted 
for the first time was 35. 
 24
Table 1b  
 
Description of Social Characteristics 
 
Variable Group Frequency Percentage 
Female 30 50 
Sex 
Male 30 50 
Unmarried 29 48.33 
Married 26 43.33 Marital Status 
Separated 5 8.33 
Hindu 52 86.67 
Christian 4 6.67 Religion 
Muslim 4 6.67 
Unemployed 34 56.67 
Occupation 
Employed 26 43.33 
Rural 36 60.00 
Region 
Urban 24 40.00 
< 1000 35 58.33 
1000 – 3000  24 40.00 Income 
> 3000 1 1.67 
 
 
 
Equal number of males and females were chosen for the study. Almost 
half of the sample was married. Four of the 5 maritally separated patients were 
women. About half the present sample (43.33 %) had been employed in some 
work prior to the illness. A majority (60 %) of the sample was derived from 
rural areas. Almost the entire sample was derived from the lower income 
population. 
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Table 1c 
  
Description of Clinical Characteristics of the Sample 
 
Variable Sub Group Frequency Percentage 
Paranoid 38 63.33 
Undifferentiated 12 20.00 
Catatonic 1 1.67 
Residual 3 5.00 
Schizophrenia 
Type 
Disorganized 6 10.00 
First 45 75 Number of 
Episodes Other 15 25 
< 1 Month 8 13.33 
1 – 6 Month 10 16.67 
6 Months – 1 
Year 
13 21.67 
1 – 2 Years 15 25.00 
Duration 
Untreated 
> 2 Years 14 23.33 
Positive 33 55.0 
Family History 
Negative 27 45.0 
Right 60 100.0 
Handedness 
Left 0 0 
Given 12 20 
ECT 
Not Given 48 80 
Atypicals 57 95 
Treatment 
Typicals 3 5 
 
The majority of the sample had paranoid schizophrenia (63.3%). The 
proportion of patients who were having the first episode of illness was 45% and 
who had a positive family history was 55%. Most patients were treated with 
atypicals only (95%). There were no left handed people in the sample. 12 
patients had been administered ECT. 
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Table 2a 
 
Description of Insight Scores in Different  
Domains by Mean (n = 60) 
 
Unawareness of Range Mean SD 
Mental Illness 1 – 5 3.78 1.28 
Effects of Treatment 1 – 5 3.55 1.35 
Social Consequences 1 – 5 4.12 1.14 
Specific Symptoms 1 – 5 3.98 0.91 
Attribution of Symptoms 1 – 5 4.02 0.99 
PANSS G12 1 – 7 4.52 1.53 
PANSS G12- Insight score on PANSS insight item. SD- standard deviation. 
 
 
Insight was assessed by two measures, the SUMD and the Insight item 
of PANSS. The average scores of unawareness were high on all sub scales of 
SUMD and the PANSS item. The mean score was lowest for unawareness of 
the effect of treatment (3.55) and highest for unawareness of social 
consequences (4.12). This difference between the insight scores of various 
dimensions of the SUMD was significant (the coefficient of concordance – 
Kendall’s W = 0.099; χ2 = 17.83; asymp. Sig = 0.001).  
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Table 2b  
 
Description of Insight Scores in Different Domains of 
SUMD by   Frequency 
 
SUMD 1C SUMD 2C SUMD 3C SUMD Aware. 
SUMD 
Attrib. Score 
frequency frequency frequency frequency frequency 
0 – 1 3 6 2 0 0 
1 – 2 8 8 3 2 1 
2 - 3 14 13 14 4 12 
3 - 4 9 13 8 17 19 
4 – 5 26 20 33 37 28 
Total 60 60 60 60 60 
SUMD 1C-Awareness of mental illness; SUMD 2C- Awareness of treatment benefit; 
SUMD 3C- Awareness of social dysfunction; SUMD Aware- average awareness 
score of all symptoms; SUMD Attrib - average attribution score of all symptoms; 
PANSS G12- insight score on PANSS insight item. SD- standard deviation 
 
 
The table gives an indication of the frequency of scores in each insight 
domain. As indicated by the previous table, many patients had a high level of 
unawareness and scored 5 for unawareness of symptoms on SUMD indicating 
a complete lack of insight. Since the level of insight was almost uniformly 
poor, rather than dividing the sample into two groups based on insight scores 
and comparing them, a correlation analysis was done between insight scores 
and relevant factors. 
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Table 3 
 
Description of Psychopathology and Depression Scores 
 
Psychopathology Range Mean (n = 60) SD 
Psychoticism 0 – 5  2.46 0.91 
Disorganization 0 – 5 2.29 0.94 
Negative Symptoms 0 – 5  2.03 0.97 
Depression 1 – 7  2.40 1.58 
SD – Standard Deviation 
 
 
The mean score on the Psychoticism domain of SAPS was 2.46 with a 
standard deviation of 0.91. The mean score on the disorganization domain of 
the SAPS was 2.29 with a standard deviation of 0.94. The average negative 
symptom score on SANS was 2.03 with a standard deviation of 0.97. The mean 
score on the depression-anxiety domain of the PANSS was 2.4 with a standard 
deviation of 1.58. 
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Table 4 
 
Description of Wisconsin Card Sorting Test (WCST) Performance 
 
WCST Score Mean (n = 60) SD 
Percent Errors ( % Error) 64.75 16.00 
Perseverative Responses (PR) 50.58 12.50 
Perseverative Errors (PE) 44.30 20.47 
Non Perseverative Errors (NPE) 20.37 9.89 
Conceptual Responses (CLR) 40.52 15.00 
Categories Completed (CC) 1.93 1.13 
Trials for 1st Category (n = 56) 28.70 14.11 
 
SD – Standard Deviation 
 
 
The average number of categories completed on the WCST was 1.93. 
No patient was able to complete all 6 categories and 4 patients did not complete 
even one category. The mean scores on each performance item of WCST were 
calculated. The average number of errors was 64.75 with a standard deviation 
of 16. The mean number of perseverative responses was 50.58 and the mean 
perseverative error score was 44.30. The average number of non perseverative 
errors was 20.37. The proportion of perseverative errors was thus greater than 
that of non perseverative errors. The average number of conceptual responses 
was 40.52. The average number of trials taken to complete the first category 
was 28.70. 
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Table 5a 
Correlation Coefficients of Insight scores and Continuous Social 
and Clinical Variables (Pearson’s Correlation) (n = 60). 
Unawareness 
of 
Age 
r  
( p ) 
Education 
 r  
( p ) 
Onset Age 
 r  
( p ) 
Duration of 
Illness   
r ( p ) 
No. of 
Admissions 
 r ( p ) 
Mental Illness - 0.043 (0.742) 
0.059 
(0.654) 
- 0.095 
(0.469) 
0.058 
(o.657) 
0.095 
(0.473) 
Effects of 
Treatment 
- 0.028 
(0.833) 
- 0.088 
(0.506) 
- 0.075 
(0.571) 
0.063 
(0.631) 
- 0.041 
(0.757) 
Social 
Consequences 
- 0.102 
(0.437) 
0.049 
(0.713) 
- 0.177 
(0.175) 
0.078 
(0.552) 
0.010 
(0.942) 
Specific 
Symptoms 
0.059 
(0.657) 
- 0.135 
(0.303) 
- 0.039 
(0.770) 
0.170 
(0.194) 
0.095 
(0.473) 
Attribution of 
Symptoms 
- 0.049 
(0.731) 
- 0.009 
(0.952) 
- 0.120 
(0.400) 
0.102 
(0.475) 
- 0.163 
(0.253) 
PANSS G12 - 0.159 (0.225) 
- 0.109 
(0.405) 
- 0.103 
(0.432) 
- 0.155 
(0.237) 
- 0.139 
(0.301) 
PANSS G12- insight score on PANSS insight item. r – Coefficient of correlation;  
p – Probability. 
 
 
Age in years, number of years of education, age at onset of illness, 
duration of illness and number of admissions were not significantly correlated 
with score on any of the dimension of insight when measured using Pearson’s 
correlation with a p value for significance fixed at 0.05. 
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Table 5b 
Difference in Insight Score (PANSS G12) among subgroups of 
Categorical Social and Clinical Variables (t - Test) 
 
Variable Sub group (n) Mean ± SD t-value p value 
Sex 
Female (30) 
Male (30) 
4.67 ± 1.63 
4.36 ± 1.45 
0.75 0.454 
Employment  
Unemployed (34) 
Employed (26) 
4.50 ± 1.52 
4.53 ± 1.57 
- 0.09 0.929 
Region 
Rural (36) 
Urban (24) 
4.30 ± 1.51 
4.83 ± 1.55 
- 1.31 0.194 
First episode  
Yes  (45) 
No (15) 
4.56 ± 1.54 
4.40 ± 1.54 
0.34 0.737 
Treatment 
Typical (3) 
Atypical  (57) 
4.00 ± 1.73 
4.54 ± 1.53 
0.59 0.554 
ECT 
Given (12) 
Not given (48) 
4.50 ± 1.24 
4.52 ± 1.61 
- 0.04 0.967 
 
There was no significant difference in mean insight scores as measured 
by PANSS insight item between any of the sub groups of social and clinical 
variables. The variables examined were sex (male vs. female), employment 
(employed vs.  unemployed), region (rural vs. urban), number of episodes (first 
episode vs. multiple), treatment administered (typical vs. atypical and ECT) 
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Table 5c 
Difference in Insight Score (PANSS G12) between subgroups 
of Categorical Social and Clinical Variables (ANOVA) 
Variable Subgroup (N) Mean ± SD SE f 
Unmarried (29) 4.72 ± 1.43 0.26 
Married (26) 4.42 ± 1.52 0.29 
Separated (5) 3.80 ± 2.16 0.96 Marital Status 
Total (60) 4.51 ± 1.53 0.19 
0.431 
Paranoid (38) 4.15 ± 1.58 0.25 
Undifferentiated (12) 5.08 ± 1.16 0.33 
Catatonic (1) 6.00 ± 0  
Residual (3) 3.67 ± 1.52 0.88 
Disorganized  (6) 5.83 ± 0.75 0.30 
Schizophrenia 
Type 
Total (60) 4.51 ± 1.532 0.19 
0.034* 
< 1Month (8) 3.75 ± 0.70 0.25 
1 - 6 Month (10) 4.50 ± 1.35 0.42 
6 - 12 Month (13) 4.84 ± 1.67 0.46 
12 - 24 (Month (15) 4.53 ± 1.64 0.42 
> 24 Month (14) 4.64 ± 1.78 0.47 
Duration 
Untreated 
Total (60) 4.51 ± 1.53 0.19 
0.624 
    * p < 0.05 
 
A one way ANOVA analysis revealed that there was no significant 
differences between mean insight score (on PANSS G 12 item) and marital 
status and duration of untreated psychosis. The analysis indicated that there 
was a significant difference between different diagnostic subtypes of 
schizophrenia with regard to insight scores measured on PANSS. The highest 
mean insight was in residual schizophrenia and the lowest in undifferentiated 
and disorganized type. 
 33
 
 
 
Table 6a 
 
Correlation between Insight Score in various domains of SUMD 
and Psychotic symptoms on SAPS (Pearson’s Correlation) (n = 60) 
 
Unawareness of Correlation Coefficient (r) 
p value significance 
Mental Illness - 0.037 0.778 No 
Effects of Treatment - 0.126 0.335 No 
Social Consequences -0.053 0.689 No 
Specific Symptoms - 0.096 0.465 No 
Attribution of Symptoms - 0.024 0.867 No 
PANSS G12 - 0.032 0.803 No 
PANSS G12 - score on PANSS insight item; r - correlation coefficient; p – 
probability. 
 
 
A correlation analysis revealed a small negative correlation between 
unawareness and severity of positive symptoms on SAPS. This was weak and 
not statistically significant. 
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Table 6b 
 
Correlation between Insight Score in various domains of SUMD and 
Disorganization on SAPS (Pearson’s Correlation)(n = 60) 
 
Unawareness of Correlation Coefficient (r)
p value significance 
Mental Illness 0.286 0.026 Yes 
Effects of Treatment 0.160 0.222 No 
Social Consequences 0.319 0.013 Yes 
Specific Symptoms 0.408 0.001 Yes 
Attribution of Symptoms 0.192 0.175 No 
PANSS G12 0.263 0.043 Yes 
PANSS G12- score on PANSS insight item; r - correlation coefficient; p – probability. 
 
 
A correlation analysis revealed that there was a significant correlation 
between scores on disorganized dimension of SAPS and the unawareness of 
mental illness, average unawareness of symptoms of mental illness and 
unawareness of social consequences. However there was no significant 
correlation between disorganization and unawareness of treatment benefit and 
misattribution. A significant correlation as also noted with insight on PANSS 
insight item.  
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Table 6c 
 
Correlation between Insight Score in various domains of SUMD 
and Negative symptoms on SANS (Pearson’s Correlation)(n = 60) 
 
Unawareness of Correlation Coefficient (r)
p value significance 
Mental Illness 0.356 0.005 Yes 
Effects of Treatment 0.350 0.222 No 
Social Consequences 0.358 0.013 Yes 
Specific Symptoms 0.441 0.001 Yes 
Attribution of Symptoms 0.332 0.175 No 
PANSS G12 0.366 0.040 Yes 
PANSS G12- score on PANSS insight item; r - correlation coefficient; p – probability. 
 
 
A correlation analysis revealed that there was a significant correlation 
between scores on severity of negative symptoms on SANS and the 
unawareness of mental illness, unawareness of symptoms of mental illness and 
unawareness of social consequences. However there was no significant 
correlation between negative symptoms and unawareness of treatment benefit 
and misattribution. A significant correlation as also noted with insight on 
PANSS insight item.  
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Table 6d 
 
Correlation between Insight Score in various domains of SUMD 
and Depression-Anxiety of PANSS (Pearson’s Correlation) (n = 60) 
 
Unawareness of Correlation Coefficient (r)
p value significance 
Mental Illness - 0.596 0.000 Yes 
Effects of Treatment - 0.497 0.004 Yes 
Social Consequences - 0.472 0.000 Yes 
Specific Symptoms - 0.540 0.002 Yes 
Attribution of Symptoms - 0.389 0.005 Yes 
PANSS G12 - 0.655 0.007 Yes 
PANSS G12- score on PANSS insight item; r - correlation coefficient; p – probability. 
 
 
A bivariate correlation analysis revealed that there was a negative 
correlation between unawareness scores on all domains of the SUMD and 
depression anxiety score on the PANSS. A similar significance was also found 
between the score of the insight item of PANSS and depression. The 
correlation was highly significant with p value less than 0.01. Thus patients 
who had a better insight were more depressed though no causal association can 
be made. 
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Table 7a 
 
Correlation between Insight Score and WCST performance 
(Pearson’s Correlation) 
 
Error PR NPE 
Unawareness of 
r p r p r p 
Mental Illness 0.427** 0.009 0.426* 0.013 - 0.203 0.120 
Effects of Treatment 0.390* 0.021 0.498* 0.027 - 0.314 0.105 
Social Consequences 0.362** 0.004 0.394* 0.024 - 0.227 0.087 
Specific Symptoms 0.417** 0.013 0.408* 0.042 - 0.135 0.304 
Symptom Attribution 0.386* 0.028 0.356* 0.035 - 0.114 0.427 
PANSS G12 0.450* 0.022 0.437** 0.009 - 0.224 0.086 
* => p < 0.05; ** => p < 0.01; r – correlation coefficient; p – probability value;  
Error = Percent Error; PR = Perseverative Resposes; NPE = Non Perseverative Errors 
 
A bivariate correlation analysis revealed that there was a significant 
correlation between the scores on unawareness and percentage of total errors, 
perseverative responses. This indicated that poor insight correlated with poorer 
performance on WCST. There was no correlation between insight scores and 
number of non perseverative errors. A similar relation was noted between 
insight score on PANSS insight item and WCST scores.  
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Table 7b 
 
Correlation between Insight Score and WCST performance        
(Pearson’s Correlation) - continued 
 
PE CLR CC 
Unawareness of 
r p r p r p 
Mental Illness 0.434* 0.011 - 0.483** 0.002 - 0.338* 0.013 
Effects of Treatment 0.452** 0.003 - 0.445** 0.004 - 0.376* 0.020 
Social Consequences 0.387* 0.041 - 0.425* 0.008 - 0.349** 0.006 
Specific Symptoms 0.387* 0.010 - 0.508** 0.000 - 0.469** 0.000 
Symptom Attribution 0.372* 0.042 - 0.410* 0.032 - 0.299* 0.033 
PANSS G12 0.461* 0.000 - 0.495** 0.000 - 0.409** 0.001 
* => p < 0.05; ** => p < 0.01; r – correlation coefficient; p – probability value; PE = 
Perseverative Errors; CLR = Conceptual Responses; CC = Categories Completed. 
 
A bivariate correlational analysis revealed that there was a significant 
correlation between the scores on unawareness and number of perseverative 
errors. There was a negative correlation between unawareness and number of 
conceptual responses and categories completed. This indicated that better 
insight correlated with better performance on WCST. A similar relation was 
noted between insight score on PANSS insight item and WCST scores. 
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Table 8 
 
Difference in Psychopathology and WCST scores between Poor And Good 
Insight groups on PANSS (G12). (t - Test) 
 
Variable Insight level (n) 
Mean Score 
± SD SE t p 
Good (17) 3.94 ± 1.67 0.40 
Depression 
Poor (43) 1.79 ± 1.03 0.15 6.02 0.001 
* * 
Good (17) 2.44 ± 0.96 0.23 
Psychoticism 
Poor (43) 2.46 ± 0.89 0.13 - 0.09 0.928 
Good (17) 1.74 ± 0.77 0.19 
Disorganization 
Poor (43) 2.50 ± 0.92 0.14 - 3.0 0.006 
* 
Good (17) 1.45 ± 0.59 0.14 
Negative 
Poor (43) 2.25 ± 1.00 0.15 - 3.08 0.003 
* 
Good (17) 43.33 ± 10.48 2.54 
% Errors  
Poor (43) 53.44 ± 12.16 1.85 - 3.01 0.004 
* 
Good (17) 45.12 ± 15.85 3.85 Perseverative 
Response Poor (43) 62.97 ± 25.08 3.82 - 2.72 0.009 
* 
Good (17) 32.82 ± 12.88 3.12 Perseverative 
error Poor (43) 48.83 ± 21.23 3.23 - 2.90 0.008 
* 
Good (17) 50.00 ± 13.43 3.25 Conceptual 
Responses Poor (43) 36.76 ± 14.01 2.13 3.30 0.002 
* 
Good (17) 2.64 ± 1.11 0.27 Categories 
completed Poor (43) 1.65 ± 1.02 0.15 3.32 0.002 
* * 
     * p < 0.05;  ** p < 0.01; SD – Standard deviation; SE – Standard error; t – t value. 
 
An alternate analysis by dividing the Sample into two groups based on 
scores on PANSS G12 item (score ≤ 3 = good insight; score ≥ 4 = poor insight) 
revealed that all variables found to be significant by correlation analysis 
continued to remain so.   
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Regression analysis 
Regression analysis was done with each dimension of the insight and the 
PANSS insight item considered as the dependent variables. The perseverative 
error and categories completed were considered as WCST variables as they 
were most often found to be associated with insight deficits and are most often 
used as indices of WCST performance  
 
Table 9a 
 
Multiple Regression Analysis with Dependent Variable PANSS G12 for 
insight and including WCST Perseverative Errors 
 
Variables Entered B SE Beta β p 
Constant 3.157 0.799  3.954 .000 
1.Schizophrenia Type 0.128 0.151 0.109 0.847 .401 
2.Depression - 0.543 0.113 - 0.557 - 4.822 .023 * 
3.Psychoticism 0.175 0.198 0.103 0.883 .381 
4.Disorganization - 0.239 0.207 - 0.146 - 1.155 .253 
5.Negative Symptoms 0.315 0.212 0.199 1.489 .143 
6.Perseverative Error 0.011 0.009 0.149 1.278 .207 
    * p < 0.05; B, SE (std. error) – unstandardized coefficients; β – Standardized 
coefficient. p – probability. 
 
Adjusted R2 = 0.439; F = 8.697; Df = 6 
Dependent Variable: PANSS G12 Insight Item 
 
 
When a multiple regression analysis was done including the significant 
items, and including the perseverative error as a WCST variable, it was found 
that only depression continued to be significant. All the variables entered could 
account for 43.9 % of the insight score (adjusted R2 = 0.439). 
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Table 9b 
 
Multiple Regression Analysis with Dependent Variable PANSS G12 for 
insight and including WCST Categories completed 
 
Variables Entered B SE Beta β p 
Constant 3.547 0.950 3.735 .000 
1.Schizophrenia Type 0.133 0.153 0.114 0.864 .391 
2.Depression - 0.605 0.115 -0.620 -5.245 .000 ** 
3.Psychoticism 0.165 0.202 0.098 0.818 .417 
4.Disorganization - 0.220 0.214 -0.134 - 1.027 .309 
5.Negative Symptoms 0.378 0.224 0.239 1.688 .097 
6.Categories Completed 0.022 0.189 0.016 0.114 .909 
    ** p < 0.01. B, SE (std. error) – unstandardized coefficients; β – Standardized 
coefficient. p – probability.  
 
Adjusted R2 = 0.422; F = 8.177; Df = 6 
Dependent Variable: PANSS G12 Insight Item 
 
When a multiple regression analysis was done including the significant 
items, and including the Categories Completed as a WCST variable, it was 
found that only depression continued to be significant. All the variables entered 
could account for 42.2 % of the insight score (adjusted R2 = 0.422) 
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Table 10a 
 
Multiple Regression Analysis with Dependent Variable SUMD 1C for 
insight and including WCST Perseverative Errors 
 
Variables Entered B SE Beta β p 
Constant 3.075 0.683 4.500 .000 
1.Schizophrenia Type 0.306 0.129 0.315 1.372 .061 
2.Depression - 0.376 0.096 - 0.464 - 3.902 .000 ** 
3.Psychoticism 0.250 0.169 0.178 1.478 .145 
4.Disorganization - 0.126 0.177 - 0.092 - 0.711 .480 
5.Negative Symptoms 0.138 0.181 0.105 0.763 .449 
6.Perseverative Errors 0.009 0.007 0.140 1.165 .249 
    ** p < 0.01. B, SE (std. error) – unstandardized coefficients; β – Standardized 
coefficient. p – probability. 
 
Adjusted R2 = 0.406; F = 7.728; Df = 6 
Dependent Variable: SUMD 1C - Unawareness of Mental Illness 
 
 
When a multiple regression analysis was done including the significant 
items, and including the perseverative error as a WCST variable, it was found 
that only depression continued to be significant. All the variables entered could 
account for 40.6 % of the insight score (adjusted R2 = 0.406). 
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Table 10b 
 
Multiple Regression Analysis with Dependent Variable SUMD 1C for 
insight and including WCST Categories completed 
 
Variables Entered B SE Beta β p 
Constant 2.943 0.804 3.659 .001 
1.Schizophrenia Type 0.318 0.130 0.328 1.449 .058 
2.Depression - 0.457 0.098 - 0.564 - 4.685 .001 ** 
3.Psychoticism 0.259 0.171 0.184 1.515 .136 
4.Disorganization - 0.080 0.181 - 0.059 - 0.444 .659 
5.Negative Symptoms 0.240 0.189 0.182 1.268 .211 
6.Categories Completed 0.151 0.160 0.134 0.943 .350 
     ** p < 0.01; SE (std. error) – unstandardized coefficients; β – Standardized 
coefficient. p – probability.  
 
Adjusted R2 = 0.401; F = 7.758; Df = 6 
Dependent Variable: SUMD 1C - Unawareness of Mental Illness 
 
 
A multiple regression analysis was done including the significant items, 
and including the Categories Completed as a WCST variable, it was found that 
only depression continued to be significant. All the variables entered could 
account for 40.10 % of the insight score (adjusted R2 = 0.401). 
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Table 11a 
 
Multiple Regression Analysis with Dependent Variable SUMD 2C for 
insight and including WCST Perseverative Errors 
 
Variables Entered B SE Beta β p 
Constant 3.154 0.777  4.058 .000 
1.Schizophrenia Type 0.186 0.147 0.182 1.270 .210 
2.Depression - 0.319 0.110 - 0.373 - 2.909 .005** 
3.Psychoticism 0.083 0.193 0.056 0.430 .669 
4.Disorganization - 0.330 0.201 - 0.230 - 1.642 .106 
5.Negative Symptoms 0.287 0.206 0.207 1.393 .170 
6.Perseverative Errors 0.015 0.009 0.228 1.761 .084 
     ** p < 0.01; SE (std. error) – unstandardized coefficients; β – Standardized  
coefficient. p – probability. 
 
Adjusted R2 = 0.309; F = 5.387; Df = 6 
Dependent Variable: SUMD 2C - Unawareness of achieved effects of 
Medication 
 
 
A multiple regression analysis was done with the dependent variable as 
SUMD Unawareness of Medication Effects and entering the significant items, 
including the Perseverative errors score as a WCST variable, it was found that 
only depression continued to be significant. All the variables entered could 
account for 30.9 % of the insight score (adjusted R2= 0.309). 
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Table 11b 
 
Multiple Regression Analysis with Dependent Variable SUMD 2C for 
insight and including WCST Categories completed 
 
Variables Entered B SE Beta β p 
Constant 4.102 0.934  4.389 .000 
1.Schizophrenia Type 0.185 0.151 0.181 1.224 .226 
2.Depression - 0.369 0.113 - 0.432 - 3.255 .002** 
3.Psychoticism 0.055 0.199 0.037 0.275 .785 
4.Disorganization - 0.335 0.210 - 0.233 - 1.590 .118 
5.Negative Symptoms 0.319 0.220 0.230 1.450 .153 
6.Categories Completed - 0.101 0.186 - 0.085 - 0.545 .588 
    ** p < 0.01; SE (std. error) – unstandardized coefficients; β – Standardized 
coefficient. p – probability. 
 
Adjusted R2 = 0.272; F = 4.676; Df = 6 
Dependent Variable: SUMD 2C - Unawareness of achieved effects of 
Medication 
 
A multiple regression analysis was done with the dependent variable as 
SUMD Unawareness of Medication Effects and entering the significant items, 
including the Categories Completed score as a WCST variable, it was found 
that only depression continued to be significant. All the variables entered could 
account for 27.2 % of the insight score (adjusted R2= 0.272). 
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Table 12a 
 
Multiple Regression Analysis with Dependent Variable SUMD 3C for 
insight and including WCST Perseverative Errors 
 
 
Variables Entered B SE Beta β p 
Constant 3.410 0.698  4.882 .000 
1.Schizophrenia Type 0.081 0.132 0.093 0.612 .543 
2.Depression - 0.236 0.099 - .327 - 2.392 .020 * 
3.Psychoticism 0.068 0.173 0.055 0.396 .694 
4.Disorganization 0.036 0.181 0.030 0.199 .843 
5.Negative Symptoms 0.185 0.185 0.158 0.999 .323 
6.Perseverative Errors 0.008 0.008 0.141 1.024 .311 
* p < 0.05; SE (std. error) – unstandardized coefficients; β – Standardized 
coefficient. p – probability. 
 
 
   Adjusted R2 = 0.217; F = 3.729; Df = 6 
   Dependent Variable: SUMD 3C - Unawareness of Social Consequences 
 
 
A multiple regression analysis was done with the dependent variable as 
SUMD Unawareness of Social Consequences and entering the significant 
items, including the Perseverative Errors score as a WCST variable, it was 
found that only depression continued to be significant. All the variables entered 
could account for 21.7 % of the insight score (adjusted R2= 0.217). 
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Table 12b  
 
Multiple Regression Analysis with Dependent Variable SUMD 3C for 
insight and including WCST Categories completed 
 
Variables Entered B SE Beta β p 
Constant 3.671 0.826 4.444 .000 
1.Schizophrenia Type 0.084 0.133 0.098 0.632 .530 
2.Depression - 0.280 0.100 - 0.387 - 2.788 .007** 
3.Psychoticism 0.062 0.176 0.050 0.354 .725 
4.Disorganization 0.050 0.186 0.041 0.269 .789 
5.Negative Symptoms 0.230 0.195 0.196 1.182 .243 
6.Categories Completed 0.019 0.164 0.019 0.113 .910 
** p < 0.01; SE (std. error) – unstandardized coefficients; β – Standardized 
coefficient. p – probability. 
 
Adjusted R2 = 0.202; F = 3.488; Df = 6 
 
Dependent Variable: SUMD 3C - Unawareness of Social Consequences 
 
A multiple regression analysis was done with the dependent variable as 
SUMD Unawareness of Social Consequences and entering the significant 
items, including the Categories Completed score as a WCST variable, it was 
found that only depression continued to be significant. All the variables entered 
could account for 20.2 % of the insight score (adjusted R2= 0.202). 
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Table 13a 
 
Multiple Regression Analysis with Dependent Variable SUMD Awareness 
Score and including WCST Perseverative Errors 
 
 
Variables Entered B SE Beta β p 
Constant 3.521 0.521 6.760 .000 
1. Schizophrenia Type 0.035 0.098 0.051 0.357 .723 
2. Depression - 0.230 0.073 - 0.397 - 3.128 .003** 
3. Psychoticism - 0.006 0.129 - 0.006 - 0.045 .965 
4. Disorganization 0.095 0.135 0.098 0.704 .484 
5. Negative Symptoms 0.207 0.138 0.220 1.496 .141 
6. Perseverative Errors 0.003 0.006 0.064 0.499 .620 
** p < 0.01; SE (std. error) – unstandardized coefficients; β – Standardized  
coefficient. p – probability. 
 
     Adjusted R2 = 0.323; F = 5.698; Df = 6 
 
     Dependent Variable: SUMD Average Unawareness of Symptom Score 
 
 
A multiple regression analysis was done with the dependent variable as 
SUMD Average Unawareness score of symptoms and entering the significant 
items, including the Perseverative Errors score as a WCST variable, it was 
found that only depression continued to be significant. All the variables entered 
could account for 32.3 % of the insight score (adjusted R2= 0.323). 
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Table 13b 
 
Multiple Regression Analysis with Dependent Variable SUMD  
Awareness Score and including WCST Categories Completed 
 
Variables Entered B SE Beta β p 
Constant 4.261 0.605 7.044 .000 
1. Schizophrenia Type 0.022 0.097 0.032 0.226 .822 
2. Depression - 0.200 0.072 - 0.346 - 2.781 .007 ** 
3. Psychoticism - 0.015 0.126 - 0.015 - 0.122 .904 
4. Disorganization 0.081 0.132 0.083 0.610 .544 
5. Negative Symptoms 0.168 0.137 0.179 1.229 .224 
6. Categories Completed - 0.013 0.008 - 0.207 - 1.564 .124 
** p < 0.01; SE (std. error) – unstandardized coefficients; β – Standardized 
coefficient. p – probability. 
 
       Adjusted R2 = 0.324; F = 5.720; Df = 6 
  
        Dependent Variable: SUMD Average Unawareness of Symptom Score 
 
 
A multiple regression analysis was done with the dependent variable as 
SUMD Average Unawareness score of symptoms and entering the significant 
items, including the Categories Completed score as a WCST variable, it was 
found that only depression continued to be significant. All the variables entered 
could account for 32.4 % of the insight score (adjusted R2= 0.324). 
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Table 14a 
 
Multiple Regression Analysis with Dependent Variable SUMD Attribution 
Score and including WCST Perseverative Errors 
 
Variables Entered B SE Beta β p 
Constant 3.685 0.670 5.505 .000 
1. Schizophrenia Type - 0.051 0.125 - 0.062 - 0.406 .687 
2. Depression - 0.173 0.093 - 0.284 -1.869 .048 
3. Psychoticism - 0.071 0.169 - 0.060 - 0.418 .678 
4. Disorganization - 0.155 0.174 - 0.155 - 0.892 .377 
5. Negative Symptoms 0.339 0.193 0.298 1.757 .086 
6. Perseverative Errors 0.012 0.008 0.223 1.482 .145 
* p < 0.05; SE (std. error) – unstandardized coefficients; β – Standardized 
coefficient. p – probability. 
 
         Adjusted R2 = 0.156; F = 2.540; Df = 6 
         Dependent Variable: SUMD Average Attribution Score 
 
 
When a multiple regression analysis was done with the dependent 
variable as SUMD Average Attribution score of symptoms and entering the 
significant items, including the Categories Completed score as a WCST 
variable, it was found that only depression continued to be significant. All the 
variables entered could account for 15.6 % of the insight score (adjusted R2= 
0.156). 
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Table 14b  
 
Multiple Regression Analysis with Dependent Variable SUMD Attribution 
Score and including WCST Categories Completed 
 
Variables Entered B SE Beta β p 
Constant 4.418 0.848 5.211 .000 
1. Schizophrenia Type - 0.050 0.128 - 0.060 - 0.387 .701 
2. Depression - 0.205 0.094 - 0.335 - 2.166 .036* 
3. Psychoticism - 0.079 0.175 - 0.068 - 0.451 .654 
4. Disorganization - 0.149 0.184 - 0.149 - 0.810 .422 
5. Negative Symptoms 0.344 0.202 0.303 1.702 .096 
6. Categories Completed - 0.083 0.166 - 0.091 - 0.503 .617 
* p < 0.05; SE (std. error) – unstandardized coefficients; β – Standardized 
coefficient. p – probability.  
 
 
           Adjusted R2 = 0.119; F = 2.125; Df = 6 
  
           Dependent Variable: SUMD Average Attribution Score 
 
 
. When a multiple regression analysis was done with the dependent 
variable as SUMD Average Attribution score of symptoms and entering the 
significant items, including the Categories Completed score as a WCST 
variable, it was found that only depression continued to be significant. All the 
variables entered could account for 11.9 % of the insight score (adjusted R2= 
0.119). 
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DISCUSSION 
Demographic Factors 
The mean age of the sample was 29.3 years. The relatively young age of 
the sample was due to the selection criteria which imposed an upper age limit 
of 40 years. The average number of years spent in school was 8.8 years. This is 
also partially due to the younger age of the sample (more people attend formal 
education currently); however it might also be due to the predominant urban 
nature of the sample as well. 
There was no relationship demonstrable between age, sex, years of 
education, marital status, employment, religion, region and income and the 
scores on the insight scales. This is in line with most of other studies which 
also do not report any correlation between insight and socio demographic 
factors. 
Insight 
 The mean scores on insight ranged between 3.55 and 4.12 for various 
insight dimensions. This is in accordance with the general view that 
schizophrenic patients have a poor insight into their illness. The average scores 
for unawareness of social consequences and attribution was lesser than the 
other domains.  
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The level of insight was lower than many of the reported studies (Young 
et al, 1993; Keshavan et al, 2004). This implies a relatively higher degree of 
unawareness among patients in the sample. This might also reflect cultural 
differences as well in the assessment of insight as has been suggested by 
Saravanan et al, (2007) and Johnson and Orrell, (1995).  
Since a majority of the sample had an insight rating of severe 
unawareness, all statistical analyses were done considering the sample as a 
single group. 
There was a significant difference between scores on different insight 
domains (the coefficient of concordance – Kendall’s W = 0.099; χ2 = 17.83; 
asymp. Sig = 0.000). However there was a significant correlation noted 
between all insight scores. This seems to indicate both the mutual relationship 
and the independence of different insight domains. Thus while a person with 
faulty attribution of illness need not be similarly impaired in awareness, he is 
more likely to be so. 
Insight and Clinical Factors 
The mean duration of the illness (4.17 yrs) and number of admissions 
(1.75) were lesser than other similar studies in this area like Freudenreich et al, 
(2004) and Dickerson et al, (1997). This could also be a reflection of the 
selection criteria adopted.  
 The lack of association between insight and duration of illness and 
number of admissions is contrary to findings by Drake et al, (2000), However, 
Amador et al, (1994) and Mintz et al, (2003) give the same fingings. The 
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results are also explainable by the relatively young age of the sample which 
could influence such an association. 
 Handedness and insight association could not be assessed as the entire 
sample was right handed. 
The majority of patients (63.33) had a diagnosis of paranoid 
schizophrenia. The proportion of the sample with a diagnosis of residual 
schizophrenia was small (5 %). This was because the study was done on 
inpatients that were more likely to have active symptomatology. 
 The nature of the episode and the treatment also did not influence 
insight. However the small number of patients receiving typical anti psychotics 
(5%) makes any meaningful comparison impossible. There was no difference 
between the ECT and Non ECT groups either in insight score or WCST 
performance (SE 7.73; t – 1.33; sig- 0.188). This might be due either to the 
small sample or the use of a single cognitive test. However, Lorena et al, 
(2004) have reported that there is no additional cognitive impairment with ECT 
treatment in schizophrenia. 
 There was a significant difference in the mean insight scores between 
different types of schizophrenia when measuring with the PANSS insight item. 
Lower insight was seen in disorganized and the undifferentiated type of illness. 
The number of patients in these groups was less and this association was lost in 
the multiple regression analysis when other factors were added. Effect of the 
type of schizophrenia on insight might be also be mediated through differences 
in other factors like greater severity of psychosis and cognitive deficits. Laroi 
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et al, (2000) also reported that undifferentiated sub type was correlated with 
greater unawareness. 
Insight and Psychopathology 
The mean score on psychopathology scores ranged between 2.46 for 
positive symptoms and 2.03 for negative symptoms. This was comparable to 
other reported studies which had used a post acute sample (Smith et al, 200o; 
Cuesta et al, 1995).    
 Though some authors (Kemp and Lambert, 1995; Amador et al, 1993; 
Mintz et al, 2003) have noted an association between insight scores and 
psychotic symptoms, we did not find any significant correlation. This finding is 
in line with the findings of Cuesta and Peralta in 1994a. One explanation for 
the finding could be the contention that insight is not state dependent in 
schizophrenia and is a stable marker of the diagnosis.  
 Disorganized symptom dimension in SAPS and PANSS have been 
associated more frequently than positive symptoms with insight. While this 
study also suggested an association between disorganization and unawareness, 
this was lost on regression analysis.  
 The initial analysis revealed a strong relation between severity of 
negative symptoms and all dimensions of insight. This was lost on subsequent 
regression analysis. This negative result is similar to the findings of other 
studies by Amador et al, (1994) and Cuesta and Peralta (1994a). However it 
could also be due to the significant confounding by other variables which had 
been measured. 
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Insight and Depression 
 There was a very significant inverse correlation between insight and 
average scores on the PANSS depression-anxiety domain. After regression 
analysis, depression was the only variable which was significantly associated 
with insight. This study thus strengthens the finding that depression is an 
outcome of good insight and that lack of insight could be a defense mechanism 
in schizophrenia.  
WCST and Insight 
The scores on the WCST were much lower than reported in similar 
studies in western countries (Keshavan et al, 2005; Smith et al, 2000). The poor 
performance of the sample on the WCST could be explained by two factors:  a) 
the post acute nature of the sample and b) it has been demonstrated that the 
WCST performance is poorer in Indian population presumably due to the 
nature of education (Kohli and Kaur, 2006). 
 The Conceptual Level Responses (CLR) and Categories Completed 
(CC) scores on WCST which are indicators of good performance were both 
significantly correlated with better insight but the relation was lost on 
regression analysis. Similarly, the total error, perseverative responses and 
perseverative errors which are indicators of poor executive function and set 
shifting also did not maintain their association during regression analysis. One 
reason for the negative result could be due to the relatively small sample size 
which could have been unable to tease out small differences. Adding to this 
could be other factors like the relative homogeneity of the sample both with 
regard to insight and WCST performance. However it must be remembered that 
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many studies have failed to turn up a significant association between insight 
and cognition as well. There was no difference among different domains of 
insight in this regard.  
 The adjusted R2 on multiple regressions varied between 0.119 and 0.401 
indicating that approximately 10 to 40 % of the insight score could be 
accounted for by the factors entered. This is in line with previous studies by 
Keshavan et al, (2004) and McCabe et al, (2002), who found that regression 
models predicted 30% and 23% of the variance in insight. 
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CONCLUSIONS 
1. Poor insight is widely prevalent in schizophrenia 
2. There was no association between socio demographic variables and 
insight. 
3. There was no association between severity of psychopathology and 
insight. 
4. There was a significant relationship between insight and depression 
anxiety domain of PANSS which was maintained even after correcting 
for other variables. 
5. There was no association between executive function and insight 
6. All the variables assessed could only account for 10 to 40 percent of 
variance in insight score.  
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LIMITATIONS 
This study has a number of limitations some of which are ubiquitous in 
studies done on this topic. The study was done on a sample of admitted 
schizophrenia patients. This makes the results of the study less generalizable to 
the overall population of schizophrenia patients. 
The sample size of 60 was relatively small to detect fine associations 
especially in the presence of multiple confounding variables. 
The cross sectional nature of the study makes it possible that the 
conclusions made may be unstable, or that they may be reflective of a 
phenomenon particular to one phase of illness. 
The proportion of the sample with good insight was low, hence reducing 
the chance of detecting any differences between groups. 
All ratings were done by the investigator only hence introducing the risk 
of an interviewer bias. 
The cross cultural validity of the SUMD is not established. 
Only a single cognitive test was used (WCST). The study did not 
measure general cognitive function or other specific aspects of cognitive 
function like memory. Though this approach is used frequently (Cuesta et al, 
1995, Collins et al, 1997 and Lysaker et al, 2003), an assessment of general 
 60
cognitive functions would have given the ability to understand the relationship 
between insight and other aspects of cognitive function. 
The study did not include premorbid function which has been studied by 
others (Keshavan et al, 2004) 
The study was naturalistic with regard to treatment and influence of 
treatment variables could not be clearly assessed. 
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STRENGTHS 
To our knowledge this is the first study in the Indian context about 
insight which tries to include the influence of cognitive factors. 
The sample was relatively homogenous for age and education and had 
an equal number of both male and females, thus reducing the risk of 
confounding. This is significant considering the difference in WCST 
performance with age and education and the absence of any standard scores for 
the Indian population and in schizophrenia. 
The sample had a relatively short duration of illness, thus minimizing 
the influence of illness chronicity on patient function. 
The study utilized the SUMD to measure insight which is a multi 
dimensional scale and reported to be sensitive in measuring the fine differences 
in insight in different domains. 
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FUTURE DIRECTIONS 
The development of indigenous insight scales to measure insight 
domains especially awareness of negative symptoms and attribution is required.  
Future studies should use a technique of comparing low and high insight 
groups so as to bring to light any small associations. 
Future studies should focus on not just performance on cognitive tests 
but also on the meta-cognitive processes which underlie thinking and insight. 
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ANNEXURE I 
 
SOCIO DEMOGRAPHIC DATA SHEET 
 
  
Serial No: ____________                       OP. No: ________________ 
 
 
Name: ____________________    Age: __________             Sex:        Male         Female  
 
 
Marital status:   Unmarried      Married  Separated 
 
 
Religion:           Hindu   Christian       Muslim           Other 
 
 
Education in Years: _________               Employment:  Yes      No 
 
 
Nature of Work:     Manual  Unskilled         Skilled 
 
 
Residence:          Urban         Rural 
 
 
Income Class:           > 900            900 - 3000   3001 - 9999        > 10,000  
 
 
CLINICAL DATA SHEET 
 
 
Type of Schizophrenia: Paranoid  Undifferentiated  Catatonic  
 
   Residual  Disorganized   Other 
 
 
First Episode:         Yes          No  Age at Onset: _____________ 
 
 
Duration Untreated: _____________     Age at First Hospitalisation: _____________ 
 
 
Number of Admissions: ____________    Duration of Illness: _____________________ 
 
 
Family History:        Yes         No   Handedness: Right     Left 
 
 
Current Treatment:  Typicals   Atypicals   Current ECT:   Yes      No 
 
 
Current Substance Use:   Yes         No 
 
 
 
 
ANNEXURE II 
 
 
Positive and Negative Syndrome Scale (PANSS) 
 
 
G 12: Lack of Judgment and Insight 
 
 Impaired awareness or understanding of one’s own psychiatric condition and 
life situation; failure to recognize past or present psychiatric illness or symptoms; 
denial of need for psychiatric hospitalization or treatment, unrealistic short term and 
long range planning;  decisions characterized by poor anticipation of consequences. 
Basis: thought cont expressed during the interview 
 
 
Depression Anxiety Domain 
 
G 2: Anxiety 
 
 Subjective experience of nervousness, worry, apprehension or restlessness, 
ranging from excessive concern about the present or future to feelings of panic. Basis 
verbal report during the interview and physical manifestations. 
 
G 3: Guilt Feelings 
 
 Sense of remorse or self blame for real or imagined misdeeds in the past. Basis: 
verbal report during the interview and influence on attitudes in the thoughts. 
 
G 4: Tension 
 
 Overt physical manifestations of fear, anxiety, agitation such as stiffness, tremor, 
profuse sweating and restlessness. Basis: verbal report attesting to to anxiety and the 
severity of physical manifestations during interview. 
 
G 6: Depression 
 
 Feelings of sadness, discouragement, helplessness and pessimism. Basis: verbal 
report of depressed mood and its observed influence on attitude and behavior. 
 
 
1 = absent; 2 = minimal; 3 = mild; 4 = moderate; 5 = moderately severe 
6 = severe; 7 = extreme 
 
 
         Average Depression - Anxiety Score: 
ANNEXURE III 
 
Scale for Assessment of Positive Symptoms (SAPS) 
 
Hallucinations 
1) Auditory Hallucinations:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
2) Voices Commenting:      0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
3) Voices Conversing:      0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
4) Somatic or Tactile Hallucinations:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
5) Olfactory Hallucinations:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
6) Visual Hallucinations:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
7) Global Rating of Hallucinations:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
Delusions  
8)   Persecutory Delusions:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
9)   Delusions of jealousy:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
10) Delusions of Guilt or Sin:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
11) Grandiose Delusions:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
12) Religious Delusions:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
13) Somatic Delusions:      0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
14) Delusions of Reference:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
15) Delusions of Being Controlled:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
16) Delusions of Mind Reading:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
17) Thought Broadcast:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
18) Thought Insertion:      0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
19) Thought Withdrawal:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
20) Global Rating of Delusions:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
Bizarre Behavior 
21) Clothing and Appearance:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
22) Social and Sexual Behavior:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
23) Aggressive and Agitated Behavior:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
24) Repetitive or Stereotyped Behavior:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
25) Global Rating of Bizarre Behavior:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
Positive Formal Thought Disorder 
26) Derailment:      0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
27) Tangentiality:      0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
28) Incoherence:      0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
29) Illogicality:       0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
30) Circumstantiality:      0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
31) Pressure of Speech:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
32) Distractible Speech:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
33) Clanging:       0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
34) Global Rating of Formal Thought Disorder:   0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
 
Inappropriate Affect  
35) Inappropriate Affect:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
 
Average Psychoticism Score    : _______ 
 
Average Disorganization Score: _______ 
 
0 = None; 1 = Questionable; 2 = Mild; 3 = Moderate; 4 = Marked; 5 = Severe 
 
ANNEXURE IV 
 
Scale for Assessment of Negative Symptoms (SANS) 
 
 
Affective Flattening or Blunting 
1) Unchanging Facial Expression:   0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
2) Decreased Spontaneous Movements:   0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
3) Paucity of Expressive Gestures:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
4) Poor Eye Contact:      0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
5) Affective Non-responsivity:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
6) Lack of Vocal Inflections:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
7) Global Rating of Affective Flattening:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
 
Alogia 
8) Poverty of Speech:      0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
9) Poverty of Content of Thought:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
10) Blocking:       0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
11) Increased Latency of Response:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
12) Global Rating of Alogia:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
 
Avolition – Apathy 
13) Grooming and Hygiene:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
14) Impersistence at Work or School:    0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
15) Physical Anergia:      0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
16) Global Rating of Avolition – Apathy:   0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
 
Anhedonia – Asociality 
17) Recreational Interests and Activities:   0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
18) Sexual Activity:      0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
19) Ability to Feel Intimacy and Closeness:   0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
20) Relationships with Friends and Peers:   0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
21) Global rating of Anhedonia – Asociality:   0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
 
Attention 
22) Social Inattentiveness:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
23) Inattentiveness during Mental Testing:   0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
24) Global Rating of Attention:     0 □ 1 □ 2 □ 3 □ 4 □ 5 □ 
 
    TOTAL NEGATIVE SYMPTOM SCORE: __________ 
 
0 = None; 1 = Questionable; 2 = Mild; 3 = Moderate; 4 = Marked; 5 = Severe 
 
ANNEXURE V 
 
Scale for assessment of Unawareness of Mental Disorders (SUMD) 
 
1) Awareness of Mental Disorder 
 
 
 
2) Awareness of Achieved Effects of Medication 
 
 
 
3) Awareness of Social Consequences of Mental Disorder 
 
 
 
 
4) Hallucinations   
Aw:  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
At  :  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
5) Delusions 
Aw:  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
At  :  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
6) Thought Disorder 
Aw:  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
At  :  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
7) Inappropriate Affect 
Aw:  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
At  :  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
8) Unusual Dress or Appearance 
Aw:  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
At  :  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
9) Stereotypic or Ritualistic Behavior 
Aw:  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
At  :  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
10) Poor Social Judgment 
Aw:  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
At  :  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
11) Poor Control of Aggressive Impulses 
Aw:  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
At  :  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
12) Poor Control of Sexual Impulses 
Aw:  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
At  :  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
C:  0)  □ 1)  □  2)  □  3)  □             4)  □           5)  □ 
C:  0)  □ 1)  □  2)  □  3)  □             4)  □           5)  □ 
C:  0)  □ 1)  □  2)  □  3)  □             4)  □           5)  □ 
 
 
 
13) Alogia 
Aw:  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
At  :  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
14) Flat or Blunted Affect 
Aw:  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
At  :  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
15) Avolition – Apathy 
Aw:  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
At  :  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
16) Anhedonia – Asociality 
Aw:  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
At  :  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
17) Poor Attention 
Aw:  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
At  :  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
18) Confusion – Disorientation 
Aw:  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
At  :  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
19) Unusual Eye Contact 
Aw:  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
At  :  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
20) Poor Social Relationships 
Aw:  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
At  :  0)  □ 1)  □   2)  □  3)  □             4)  □           5)  □ 
 
 
Average Awareness Score (Average of items scored in 4 – 20): __________ 
 
Average Attribution Score (Average of items scored in 4 – 20): ___________ 
 
 
0 = Cannot be assessed; 1 = Clearly believes; 3 = Unsure but can entertain the 
idea; 5 = Complete Denies the possibility. 
 
C – Current; Aw – Awareness; At – Attribution. 
ANNEXURE VI 
 
 
 
 
 
 
 
 
 
 
“Please sort the 60 cards under the 4 samples. I won’t tell you the 
rule, but I will announce every mistake.” 
Wisconsin Card Sorting Test (WCST) 
